|Online Slide/Audio Symposium|
Satellite Symposium of the American Society of Nephrology 32nd Annual Scientific Meeting,
Genzyme Therapeutics, ASN Corporate Sponsor
Supported by an unrestricted grant from Genzyme Therapeutics
Consequences of Hyperphosphatemia: Are We Accepting the Unacceptable?
You need to REGISTER WITH HDCN (it's free) before you can access these talks. This program offers 1.5 hours of Category One CME Credit through the University of Minnesota. For CME-related information click here
Role of Phosphate in the Pathogenesis of
Eduardo Slatopolsky, M.D.
Acid-Base and the Skeleton
David Bushinsky, M.D.
Epidemiology and Quality Improvement in Phosphate Management
Glenn Chertow, M.D., M.P.H.
Questions and Answers
Drs. Slatopolsky, Bushinsky, and Chertow
Compiled by course faculty
David Bushinsky, M.D.,
Professor of Medicine, Pharmacology, and Physiology; Chief, Nephrology Unit, University of Rochester
Medical Center, Rochester, NY.
Glenn Chertow, M.D., M.P.H. Professor of Medicine, University of California at San Francisco, San Francisco, CA.
Eduardo Slatopolsky, M.D., Professor of Renal Diseases in Medicine, Washington University, St. Louis, MO
Back to symposia list by topic
Back to symposia list by meeting
Back to HDCN home page